PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-7.84%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.4B
AUM Growth
+$1.4B
(-8.8%)
Cap. Flow
+$76.5M
Cap. Flow
% of AUM
5.45%
Top 10 Holdings %
Top 10 Hldgs %
48.29%
Holding
242
New
48
Increased
30
Reduced
52
Closed
51
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$32.5M |
| 2 |
Aclaris Therapeutics
ACRS
|
$22.5M |
| 3 |
Galapagos
GLPG
|
$20.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$15.8M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$15.5M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$17.2M |
| 2 |
DexCom
DXCM
|
$15.7M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$13.5M |
| 4 |
Assertio
ASRT
|
$13.4M |
| 5 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$12.4M |
Sector Composition
| 1 | Healthcare | 94.07% |
| 2 | Consumer Discretionary | 0.07% |
| 3 | Industrials | 0.05% |
| 4 | Energy | 0.02% |
| 5 | Financials | 0% |
